The funding will support the edtech company as it scales its specialist online provision and rolls out its Bloom platform.
"Gaia Learning was born out of a passion for ensuring neurodivergent children can access education that is best suited to their unique needs. Our first funding round really helped us to get this idea off the ground, allowing us to grow our team and accelerate the development of Bloom. Most importantly, it has enabled us to support more neurodivergent learners and help more schools deliver effective support for children with additional needs."
SCVC led the pre-seed round with backing from Deep Science Ventures and Cambridge Enterprise VC to help the startup expand its team and partnerships.
"Cellular machinery still rejects these therapies, limiting long-term effectiveness and forcing costly, unsafe doses. Our platform introduces a vital shift from trial-and-error screening to repeatable, engineering-driven DNA design,"
The pre-seed round was led by Episode 1 with angel backing from executives at Wise, Revolut, Deliveroo, and Alphabet.
"When I found an error in my own tax return while testing the platform, I was shocked – I’d paid for professional help, I work in finance, and I was still left wondering whether everything had actually been done correctly. That simply shouldn’t still be the case in 2026,"
Playfair led the pre-seed round for the London-based conversational commerce startup, with participation from several prominent tech angels.
"WhatsApp is about to become the default commerce channel for businesses. OpenAI wants those conversations to happen in ChatGPT and Google wants them in Search, but customers already spend their time on WhatsApp. We built Wassist so brands can own those conversations themselves,"
The investment was backed by the South West Investment Fund via The FSE Group.
"Difficulty taking tablets is a common problem in paediatrics but extends to adults experiencing swallow impairment, including those suffering from serious conditions such as stroke, dementia and some forms of cancer. Our liquid products are effective and stable at room temperature with a long shelf life, improving medication adherence, dosage accuracy and convenience for the NHS, patients, and caregivers. We are thrilled to receive this investment, which will help us make a significant impact on the global pharmaceutical landscape."
-20webclip.png)
